Drug Type Monoclonal antibody |
Synonyms KDDF-201210-05 |
Target |
Action inhibitors |
Mechanism CLEC14A inhibitors(C-type lectin domain containing 14A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dystrophy, Macular | Preclinical | South Korea | - | |
| Glaucoma | Discovery | South Korea | - | |
| Neoplasms | Discovery | South Korea | - |






